• Mashup Score: 1
    April Salama on Managing Melanoma Brain Metastases - The ASCO Post - 3 year(s) ago

    NCCN 2021 Virtual Annual Conference April K. Salama, MD, of Duke Cancer Institute, discusses the shift in recent years, as more effective therapies have become available, toward integrating systemic upfront treatment of patients with brain metastases from cutaneous melanoma; pivotal studies that have provided key data; and the need for…

    Source: ascopost.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ASCOPost
      ASCOPost

      April K. Salama, MD, on Managing Melanoma Brain Metastases https://t.co/0J56obhenG #melsm #oncology #cancer #NCCN21 #NCCN2021 @DukeCancer https://t.co/N5Vw6yHvWY

  • Mashup Score: 5
    Thomas Varghese on the Effects of the COVID-19 Pandemic on Cancer Care - The ASCO Post - 3 year(s) ago

    NCCN 2021 Virtual Annual Conference Thomas K. Varghese, Jr, MD, of Huntsman Cancer Institute at the University of Utah, summarizes a panel discussion on how the COVID-19 pandemic has interrupted cancer screenings, when telemedicine works and when it doesn’t, opening alternative care sites in the community, and the emotional and mental toll the…

    Source: ascopost.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ASCOPost
      ASCOPost

      Thomas K. Varghese, Jr, MD, on the Effects of the COVID-19 Pandemic on Cancer Care https://t.co/nCMoSHeyTV #COVID19 #cancer #oncology #NCCN21 #NCCN2021 @huntsmancancer @TomVargheseJr https://t.co/5ctZx2RwZ8

  • Mashup Score: 1
    Mary Mulcahy and Crystal Denlinger on NCCN Guidelines Updates Gastric and Esophageal Cancers - The ASCO Post - 3 year(s) ago

    NCCN 2021 Virtual Annual Conference Crystal S. Denlinger, MD, of Fox Chase Cancer Center, and Mary F. Mulcahy, MD, of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, discuss biomarkers for determining treatment; immune checkpoint inhibitors; when to employ such treatments as platinum/fluoropyrimidine and fam-trastuzumab deruxtecan-nxki; and…

    Source: ascopost.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ASCOPost
      ASCOPost

      Mary F. Mulcahy, MD, and Crystal S. Denlinger, MD, on NCCN Guidelines Updates: Gastric and Esophageal Cancers https://t.co/xZotmdKjgz #esocsm #oncology #cancer #NCCN21 #NCCN2021 @DrCrystalD @FoxChaseCancer @MFMulcahyMD @LurieCancer https://t.co/DQ6JvWNeG3

  • Mashup Score: 0
    Alexander Perl on Acute Myeloid Leukemia: Treatment Updates - The ASCO Post - 3 year(s) ago

    NCCN 2021 Virtual Annual Conference Alexander E. Perl, MD, of the Abramson Cancer Center at the University of Pennsylvania, discusses the major changes in 2021 to the NCCN Clinical Practice Guidelines in Oncology for managing acute myeloid leukemia, including venetoclax plus azacitidine, a new standard of care in patients ineligible for intensive induction; oral…

    Source: ascopost.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ASCOPost
      ASCOPost

      Alexander E. Perl, MD, on Acute Myeloid Leukemia: Treatment Updates https://t.co/4RbIEs1qGe #NCCN21 #NCCN2021 #leusm #hematology @PennMedicine https://t.co/M9UDaxodu0

  • Mashup Score: 2
    Lori Wirth on Advanced Thyroid Carcinoma Evolving Systemic Therapy Options - The ASCO Post - 3 year(s) ago

    NCCN 2021 Virtual Annual Conference Lori J. Wirth, MD, of Massachusetts General Hospital Cancer Center, discusses the common molecular alterations across thyroid cancer subtypes; targeted treatments for BRAF V600E–mutant, NTRK–fusion positive, and RET–altered disease; and optimal therapies for patients with multiple types of thyroid cancer. …

    Source: ascopost.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ASCOPost
      ASCOPost

      Lori J. Wirth, MD, on Advanced Thyroid Carcinoma: Evolving Systemic Therapy Options https://t.co/bZZb6XNnso #thycsm #oncology #cancer #NCCN21 @MGHCancerCenter #NCCN2021 https://t.co/HamMyaZ4eI

  • Mashup Score: 2
    Shaji Kumar on Multiple Myeloma NCCN Guidelines Update - The ASCO Post - 3 year(s) ago

    NCCN 2021 Virtual Annual Conference Shaji K. Kumar, MD, of the Mayo Clinic Cancer Center, discusses the latest data on treating patients with multiple myeloma, including standard-of-care induction before stem cell transplant; the role of quadruplet induction; long-term results with the combination of daratumumab, lenalidomide, and dexamethasone in those…

    Source: ascopost.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ASCOPost
      ASCOPost

      Shaji K. Kumar, MD, on Multiple Myeloma: NCCN Guidelines Update https://t.co/KXPYnaSeCr @myelomaMD @MayoClinic #NCCN21 #NCCN2021 #mmsm #hematology @NCCN https://t.co/eMQ1aG22fn

Load More